Xconomy National

Archives

by in
Entry Author Date Location
Vertex Vows to Fight On With Alios Drugs in High-Stakes Hepatitis C Race Luke Timmerman 01/24/12 Boston
Alnylam Cuts One-Third of Workforce, To Save Cash for RNAi Clinical Plans Luke Timmerman 01/19/12 Boston
Alnylam, Aveo, Biogen, & More Boston Life Sciences Newsmakers Erin Kutz 01/06/12 Boston
Merck Pours $17M Into Physicians Interactive’s Web Tools for Docs Arlene Weintraub 01/05/12 Boston
Alnylam Gets First Hint of Effectiveness for RNAi Cholesterol-Lowering Drug Luke Timmerman 01/04/12 Boston
Merck Leads $10M Funding of HIV Diagnostics Firm Daktari Arlene Weintraub 01/03/12 Boston
The Top 10 Traffic-Getting Stories at Xconomy San Diego Bruce V. Bigelow 12/28/11 San Diego
Xconomy Storms NYC: Top Ten Topics in the Big Apple in 2011 Arlene Weintraub 12/27/11 New York
Momenta, Baxter Team Up on Biosimilars Erin Kutz 12/23/11 Boston
Amgen, Watson Strike $400M Deal for Biosimilar Cancer Drugs Luke Timmerman 12/19/11 National
Third Rock Looks to Fight Fat in a New Way, With Ember Therapeutics Luke Timmerman 12/15/11 Boston
Merck Chemists Use High-Tech Science to Combat Alzheimer’s Disease Challenge Arlene Weintraub 12/14/11 New York
The Hepatitis C Market: Biotech’s Version of the Daytona 500 Luke Timmerman 12/12/11 National
NanoBio, Merck to Collaborate on Gates-Funded RSV Vaccine Sarah Schmid 12/09/11 Detroit
Dendreon Pulls In $125M By Selling Royalty Slice of Merck’s Hepatitis C Drug Luke Timmerman 12/06/11 Seattle
Biogen Idec Boosts Biogenerics Strategy With $300M Samsung Joint Venture Arlene Weintraub 12/06/11 Boston
Eli Lilly Pumps $4M into IDRI to Continue Hunt for TB Drugs Luke Timmerman 11/17/11 Seattle
AMAG Stock Rises, Ariad Drug Shows Improved Safety, Rhythm Adds Merck Veteran as CEO, & More Boston-Area Life Sciences News Erin Kutz 11/11/11 Boston
Merck Unveils Alzheimer’s and Diabetes Projects, Personnel Changes Arlene Weintraub 11/10/11 New York
Rhythm Adds Former Merck VP as CEO Erin Kutz 11/09/11 Boston
Biopharma Industry Meetings Could Use Some Fresh Voices Stewart Lyman 11/01/11 Seattle
Portola Grabs $45M Upfront From Biogen Idec to Develop Autoimmune Drugs Luke Timmerman 10/27/11 San Francisco
NextBio Sees Growth in Next Market: Physicians Seeking Help Interpreting Individual Genomes Luke Timmerman 10/18/11 San Francisco
Anadys Pharmaceuticals Surprises the Street, Gets Acquired by Roche for $230M Luke Timmerman 10/17/11 San Diego
Stem Cell Therapy: A Process With a Promise Drew McUsic 10/10/11 Seattle
Smoke on the Water: Fireworks at the Cleveland Clinic Medical Innovation Summit Lisa Suennen 10/10/11 San Francisco
When Will Software for the Genome Take Off? Find out Oct. 24 Luke Timmerman 10/07/11 San Francisco
Celgene Pays Agios $20M, Lycera Adds Cambridge CEO, Getinge Buys Atrium Medical, & More Boston-Area Life Sciences News Erin Kutz 10/07/11 Boston
Lycera Hires New CEO, Plans Move to U-M Research Center Sarah Schmid 10/06/11 Detroit
Merck Fine-Tunes Biosimilars Strategy as FDA Guidelines Loom Arlene Weintraub 10/05/11 New York
Page 1 of 11 next page »
    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.